Astrogliosis: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Reactive_astrocytes_-_lfb_-_high_mag.jpg|Reactive astrocytes stained with Luxol fast blue at high magnification | |||
File:Variations_in_glial_scarring.jpg|Variations in glial scarring | |||
File:2010-3-15_rGFAP_1-4000_1-200_Hip_20x(4).tif|Astrogliosis | |||
</gallery> | |||
Revision as of 04:16, 18 February 2025
Astrogliosis is a process that occurs in the central nervous system (CNS) in response to various forms of injury, disease, or aging. It involves changes in the morphology and function of astrocytes, the most abundant type of glial cell in the CNS.
Overview
Astrogliosis is characterized by a series of changes in astrocytes, including hypertrophy (increase in cell size), hyperplasia (increase in cell number), and increased production of glial fibrillary acidic protein (GFAP), a protein that is used as a marker of astrocyte activation. These changes are thought to be a protective response aimed at limiting the spread of damage and restoring homeostasis. However, in some cases, astrogliosis can also contribute to disease progression and neurodegeneration.
Causes
Astrogliosis can be triggered by a wide range of CNS insults, including traumatic brain injury, stroke, infection, neurodegenerative diseases, and aging. The severity and duration of the insult can influence the extent and characteristics of the astrogliotic response.
Pathophysiology
During astrogliosis, astrocytes undergo morphological and functional changes that are aimed at limiting the spread of damage and restoring homeostasis. These changes include hypertrophy, hyperplasia, and increased production of GFAP. In addition, astrocytes can also secrete various cytokines, chemokines, and other molecules that can influence the behavior of other cells in the CNS.
Clinical significance
While astrogliosis is generally considered to be a protective response, in some cases it can also contribute to disease progression. For example, in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, chronic astrogliosis can lead to the formation of a glial scar, which can impede neuronal regeneration and contribute to ongoing neurodegeneration.
